What's New in Cardiac MRI? — August 28, 2026
AI-summarised digest of 62 PubMed articles on Cardiac MRI published in the last 7 days.
Jump to category
What’s New in Cardiac MRI?
August 28, 2026 · 62 articles · 15 research themes · covering August 21, 2026 – August 28, 2026
Overview
Across this week’s set, cardiac imaging is increasingly moving from “what the heart looks like” to “what the heart is doing and why.” Multiple studies emphasize tissue-level characterization—native T1/ECV for diffuse fibrosis, LGE-derived microvascular injury phenotypes (MVO/IMH) after STEMI, and mapping-based quantification in atrial fibrillation and other remodeling states. Together, these works reinforce a shift toward mechanistic biomarkers that can refine prognosis and risk stratification beyond conventional functional measures like LVEF.
A second dominant theme is improving how clinicians detect and act on arrhythmia risk. Evidence spans both substrate-focused CMR approaches (e.g., quantitative LGE processing in HCM, ECV-based AF prediction, and scar-guided ICD trial design) and workflow innovations for VT mapping and ablation (including MRI-informed functional substrate mapping and comparisons of imaging-guided vs conventional ablation strategies). The overall direction is toward more reproducible, quantitative imaging inputs that can personalize electrophysiology decisions.
Finally, the digest highlights the growing importance of standardization, automation, and patient-centered feasibility. Papers address scanner/protocol variability and the need for locally validated reference ranges, while others introduce accelerated or free-breathing CMR to reduce sedation burden, and AI models to automate echocardiographic LVEF/strain. Complementing these technical advances, several disease-focused reports (amyloidosis, inflammatory myocarditis, systemic autoimmune vasculitis, and post-sepsis injury) show how multimodality imaging can prevent misdiagnosis and enable earlier, more targeted therapy—often with long-term follow-up evidence where available.
Cardiac MRI/CT Image Reconstruction & Quantification Methods
Completely free-breathing cardiac MRI using deep learning reconstruction reduces sedation and scan time in children.
This study compared a highly accelerated single–cardiac-cycle (1RR) free-breathing cine CMR acquisition using deep learning reconstruction with conventional segmented breath-hold cine imaging in 150 pediatric patients requiring CMR. The deep learning free-breathing approach reduced scan duration and decreased the need for sedation/anesthesia compared with breath-hold imaging. Scientifically and clinically, it supports a more child-friendly CMR workflow that can lower procedural burden while maintaining feasibility in young or ill children.
Gupta A, Long W, Young S et al. · Pediatric radiology · (2026) · View on PubMed ↗
High frequency edge network for accurate cardiac structure segmentation.
This study developed and evaluated HF-EdgeNet, a high-frequency edge–driven encoder–decoder deep learning framework for cardiac magnetic resonance imaging (MRI) segmentation in order to improve boundary delineation of cardiac structures. The key finding is that injecting high-frequency guidance via a High Frequency Edge Transformer (HF-EdgeT), compensating for high-frequency degradation during downsampling with a High Frequency Adaptive module (HF-Adapte), and using a Semantic Edge Bridge (SEB) block improves segmentation accuracy by leveraging discriminative anatomical cues encoded in high-frequency components. Clinically, more accurate cardiac structure segmentation can support improved downstream cardiac assessment and potentially reduce variability in quantitative imaging workflows.
He S, Xiong H, Wang W et al. · iScience · (2026) · View on PubMed ↗ · Free PDF ↗
Cardiac MRI Tissue Characterization, Fibrosis & Edema Biomarkers
Diffuse Fibrosis in Hypertrophic Cardiomyopathy: Incremental Prognostic Value of Extracellular Volume.
This JACC Advances study assessed whether cardiac magnetic resonance (CMR)–derived extracellular volume (ECV) from T1 mapping provides incremental prognostic value in 1,050 consecutive hypertrophic cardiomyopathy (HCM) patients with preserved LVEF (≥50%) undergoing CMR (2012–2021). Higher ECV reflecting diffuse myocardial fibrosis improved risk prediction beyond established clinical and imaging variables, over and above late gadolinium enhancement (LGE) burden. The findings support incorporating ECV into CMR risk models to better identify HCM patients at higher risk of adverse outcomes.
Keen SK, Sheashaa H, Shah S et al. · JACC. Advances · (2026) · View on PubMed ↗
Left Ventricular Fibrosis on T1 Mapping is Associated with Increased Risk of Incident Atrial Fibrillation: Results from the Multi-Ethnic Study of Atherosclerosis (MESA).
This study evaluated whether baseline left ventricular extracellular volume fraction (LV-ECV) measured by cardiac magnetic resonance (CMR) T1 mapping predicts incident atrial fibrillation (AF) in 1,261 Multi-Ethnic Study of Atherosclerosis (MESA) participants free of AF at baseline. Higher LV-ECV (reflecting diffuse myocardial fibrosis) was independently associated with increased risk of developing incident AF during prospective follow-up. These findings support using CMR T1/ECV fibrosis quantification as a noninvasive biomarker to improve AF risk stratification beyond traditional clinical factors.
Ebrahimihoor E, Salameh E, Aronis KN et al. · European heart journal. Cardiovascular Imaging · (2026) · View on PubMed ↗
A contrast-enhanced CMR-based risk score integrating microvascular obstruction and intramyocardial hemorrhage extent for prognostic evaluation.
This retrospective multicenter study assessed whether combining microvascular obstruction (MVO) extent and intramyocardial hemorrhage (IMH) extent on contrast-enhanced CMR improves prognostic prediction of major adverse cardiovascular events (MACE) in 568 patients with ST-elevation myocardial infarction (STEMI). The authors report that a contrast-enhanced CMR-based risk score integrating MVO (via late gadolinium enhancement) and IMH (via T2* mapping and T2-weighted imaging) stratified patients into higher- and lower-risk groups and outperformed or complemented existing CMR and clinical scores (Eitel, Glasgow, and GRACE). Clinically, this provides a CMR-driven approach to refine post-STEMI risk prediction by capturing distinct microvascular injury phenotypes.
Gu XY, Yin TX, Yu LY et al. · Insights into imaging · (2026) · View on PubMed ↗
Assessment of Left Ventricular Myocardial Fibrosis and Edema in Atrial Fibrillation Using Cardiovascular Magnetic Resonance.
This JoVE protocol studied cardiovascular magnetic resonance (CMR) quantitative mapping (T1 mapping, T2 mapping, and extracellular volume [ECV] fraction) to assess left ventricular myocardial fibrosis and edema in patients with atrial fibrillation (AF). It found that CMR mapping techniques can quantify myocardial tissue abnormalities relevant to AF-related remodeling beyond conventional functional imaging. The scientific significance is that standardized CMR methods can improve characterization of AF-associated ventricular substrate, supporting prognosis and potentially guiding therapy.
Wang Y, Zhou J, Zhu Y · Journal of visualized experiments : JoVE · (2026) · View on PubMed ↗
Cardiac Imaging Biomarkers for Arrhythmia Risk & Ablation
Enhancing risk prediction for sudden cardiac death: quantitative late gadolinium enhancement analysis in hypertrophic cardiomyopathy.
This single-center retrospective study assessed how different quantitative late gadolinium enhancement (LGE) analysis methods predict sudden cardiac death (SCD) or aborted SCD in 617 patients with hypertrophic cardiomyopathy (HCM). It compared n-standard deviation (n-SD) thresholding (including multiple thresholds) and full width at half maximum (FWHM) approaches, defining a “gray zone” between thresholds, and evaluated which LGE quantification strategy best discriminated risk. The work supports more precise, quantitative LGE processing to improve SCD risk prediction in HCM beyond qualitative scar assessment.
Wang L, Zhang H, Lu G et al. · Insights into imaging · (2026) · View on PubMed ↗ · Free PDF ↗
MRI-guided multipolar functional substrate mapping identifies intramural conduction corridors: The TRAMPOLINE VT study.
The TRAMPOLINE VT study evaluated MRI-guided multipolar functional substrate mapping in 18 patients with ischaemic cardiomyopathy undergoing ventricular tachycardia (VT) ablation, comparing electrode spacing and multipolar signal annotation strategies across endocardial and mid-myocardial substrate. It found that mapping performance for identifying conduction delay corridors depended on catheter electrode spacing and the functional mapping workflow using a single sensed extra-stimulus (SE) protocol, enabling detection of intramural conduction pathways co-registered to MRI scar models. This supports a more reproducible, MRI-informed approach to targeting mid-myocardial VT substrate beyond conventional endocardial mapping, potentially improving ablation precision in ischaemic VT.
Maclean E, Tonko J, Creta A et al. · Heart rhythm · (2026) · View on PubMed ↗
Imaging-Guided Versus Conventional Ventricular Tachycardia Ablation in Ischemic Cardiomyopathy: A Systematic Review and Meta-Analysis.
This systematic review and meta-analysis studied imaging-guided versus conventional ventricular tachycardia (VT) ablation strategies in adults with ischemic cardiomyopathy (ICM). It found that the incremental benefit of advanced imaging guidance over conventional approaches for VT recurrence remains uncertain based on pooled comparative outcomes. The clinical significance is that it informs evidence-based selection of imaging-guided ablation workflows for ICM patients undergoing VT ablation.
Ahmed S, Sawalha K, Sharief M et al. · Journal of arrhythmia · (2026) · View on PubMed ↗ · Free PDF ↗
Left Ventricular Summit Ventricular Tachycardia Identified by Electrocardiographic Pattern Recognition and Managed With Radiofrequency Ablation.
This case report studied a 66-year-old man with left ventricular summit ventricular tachycardia (LVSVT) identified using 12-lead electrocardiographic pattern recognition. It found that characteristic ECG features (including left bundle branch block-like morphology, inferior axis, and early precordial transition) enabled targeted localization and successful management with radiofrequency ablation. The clinical significance is that ECG pattern recognition can guide effective ablation planning for this anatomically specific VT substrate.
Moreira MG, Hardy CA, Costa LMAD et al. · The American journal of case reports · (2026) · View on PubMed ↗ · Free PDF ↗
Cardiac Imaging Biomarkers for Heart Failure & Remodeling
Cardiovascular Magnetic Resonance to Guide Defibrillator Implantation for LVEF of 36% to 50%: The CMR GUIDE Randomized Clinical Trial.
The CMR GUIDE randomized clinical trial tested whether scar-guided implantable cardioverter-defibrillator (ICD) implantation reduces sudden cardiac death (SCD) or hemodynamically significant ventricular arrhythmia (HSVA) in patients with LVEF 36%–50% and myocardial scar assessed by late gadolinium enhancement on CMR. The trial design targets a population not covered by current guideline thresholds (LVEF ≤35%) by using CMR-defined arrhythmic substrate. If effective, this approach could change primary-prevention ICD selection by using CMR scar rather than LVEF alone.
Selvanayagam JB, Cleland JGF, Hillis GS et al. · JAMA · (2026) · View on PubMed ↗
Low Ventricular Chamber Stiffness Identifies a High-Risk Eccentric Remodeling Phenotype in the Fontan Circulation: A FORCE Registry Analysis.
This FORCE registry analysis studied ventricular chamber stiffness in Fontan circulation patients by quantifying the end-diastolic pressure–volume relationship (exponential coefficient β) to identify a high-risk eccentric remodeling phenotype. The key finding was that low ventricular chamber stiffness identifies patients with higher risk, linking altered mechanical properties to clinical prognosis. This is significant because it provides a physiology-based biomarker that may improve risk prediction and guide management in Fontan patients.
Van den Eynde J, Van De Bruaene A, Slesnick T et al. · Circulation · (2026) · View on PubMed ↗
Prognostic Value of Strain Imaging Measurements in Patients with Non-ischemic Cardiomyopathy: A Scoping Review.
This PRISMA-ScR–guided scoping review summarized evidence on the prognostic value of myocardial strain imaging in non-ischemic cardiomyopathy (NICM), focusing on whether strain parameters add risk prediction beyond left ventricular ejection fraction (LVEF). Across included studies, the review concludes that myocardial strain—particularly left ventricular global longitudinal strain (LVGLS)—may provide independent prognostic information, though its role and standardization in NICM remain incompletely defined. The synthesis supports ongoing efforts to incorporate strain metrics into NICM risk models while addressing heterogeneity in acquisition and reporting.
Mohammed D, Saeed H, Rayyan A et al. · Cardiology in review · (2026) · View on PubMed ↗
Comparative Performance of Speckle Tracking Echocardiography and CMR Feature Tracking for Right Ventricular Myocardial Fibrosis in advanced heart failure.
This study compared right ventricular free wall longitudinal strain (RVFWLS) derived from three noninvasive techniques—2D speckle-tracking echocardiography (2D-STE), 3D speckle-tracking echocardiography (3D-STE), and cardiac magnetic resonance feature tracking (CMR-FT)—to evaluate right ventricular myocardial fibrosis (RVMF) in advanced heart failure. Using histopathological RVMF as the gold standard, it aimed to determine which imaging-derived RVFWLS metric is the most robust marker of RVMF. The clinical significance is that identifying the most reliable strain method could improve noninvasive fibrosis assessment and risk stratification in advanced heart failure patients.
Gao L, Cao Y, Dong N et al. · Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography · (2026) · View on PubMed ↗
Multimodal Framework of Left Heart-Pulmonary Vascular Remodeling Underlying Right Ventricular Failure in PH-HFpEF.
This study developed a multimodal mechanistic framework for right ventricular (RV) failure in pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) by integrating vascular mechanics with myocardial transcriptomics. In a predominantly retrospective PH-HFpEF cohort (n=48), participants underwent clinical evaluation, echocardiography, cardiac MRI, and invasive cardiopulmonary exercise testing, and the approach linked cardiac MRI-derived RV ejection fraction with transcriptomic and vascular remodeling features. The framework is intended to clarify causal pathways driving RV dysfunction in PH-HFpEF and guide future targeted interventions.
Raza F, Gregorich ZR, Freeman J et al. · Circulation. Heart failure · (2026) · View on PubMed ↗ · Free PDF ↗
Valvular Heart Disease Imaging & Post-Intervention Recovery
Myocardial Fibrosis and Reverse Remodeling After Valve Replacement in Chronic Aortic Regurgitation.
This prospective longitudinal observational study quantified reverse remodeling, functional recovery, and symptom change after aortic valve replacement (AVR) in patients with chronic severe aortic regurgitation (AR) and tested whether myocardial fibrosis predicts incomplete recovery. Patients underwent paired imaging assessments before and after AVR, and the study evaluated the relationship between baseline myocardial fibrosis and the degree of post-surgical improvement. The findings aim to determine whether fibrosis represents irreversible scarring that could influence timing of AVR and post-operative risk stratification.
Thornton GD, Bennett JB, Aziminia N et al. · JAMA cardiology · (2026) · View on PubMed ↗
Cardiovascular Risk Stratification Using Imaging (Coronary, Adipose, Other Biomarkers)
The additive value of coronary calcium in identifying cardiovascular risk in ageing people with HIV.
This study evaluated whether coronary artery calcium scores (CACS) add predictive value for cardiovascular risk in 779 aging people with HIV (median age 55) who underwent coronary calcium scanning. Coronary calcium predicted adverse outcomes such as major adverse cardiovascular events (MACE), death, and heart failure better than Q-risk scores. The results support using CACS to improve cardiovascular risk stratification in people with HIV beyond traditional risk scores.
Varadarajan M, Byrne R, Al-Hussaini A et al. · AIDS (London, England) · (2026) · View on PubMed ↗
Epicardial Adipose Tissue and Long-Term Outcomes in CMR-Confirmed MINOCA.
This single-center retrospective study evaluated whether epicardial adipose tissue (EAT) volume measured by CMR predicts long-term major adverse cardiovascular events (MACE) in 117 CMR-confirmed MINOCA patients with ischemic myocardial injury patterns. EAT was associated with subsequent MACE and provided incremental prognostic utility beyond CMR-confirmed ischemic injury characterization. Clinically, this suggests EAT quantification could refine risk stratification and follow-up intensity in MINOCA patients.
Chen L, Chen W, Zong D et al. · JACC. Asia · (2026) · View on PubMed ↗
Impact of Dapagliflozin on MRI-Derived Epicardial Adipose Tissue: Secondary Imaging Analysis of a Randomized Trial.
This JMRI secondary analysis studied whether the SGLT2 inhibitor dapagliflozin reduces epicardial adipose tissue (EAT) independently of weight change in adults with type 2 diabetes mellitus (T2DM) without overt cardiovascular disease in a randomized, placebo-controlled trial. The key finding was that EAT thickness changes on MRI were assessed longitudinally to determine whether any reduction with dapagliflozin reflects a direct drug effect rather than secondary weight loss. Clinically, clarifying the weight-independent impact of dapagliflozin on EAT supports more precise use of imaging biomarkers for cardiovascular risk modification in T2DM.
Cha MJ, Firoozeh N, Naumova AV et al. · Journal of magnetic resonance imaging : JMRI · (2026) · 1 citations · View on PubMed ↗ · Free PDF ↗
Association of cardiac magnetic resonance imaging parameters with N-terminal pro-B-type natriuretic peptide levels.
This retrospective single-center study evaluated associations between serum NT-proBNP levels and cardiac magnetic resonance (CMR) parameters in 204 patients who had NT-proBNP measured within 7 days of CMR. The key finding was that higher NT-proBNP categories (normal, high, extremely high) correlated with differences in CMR-derived structural and functional measures such as left ventricular ejection fraction, myocardial mass, and left atrial diameter, along with tissue-characterization metrics (e.g., late enhancement/other characterization as reported). Scientifically and clinically, linking NT-proBNP to specific CMR phenotypes can improve risk stratification and interpretation of biomarker-driven heart failure severity.
Doğan İ, Memis KB, Şahin D et al. · Diagnostic and interventional radiology (Ankara, Turkey) · (2026) · View on PubMed ↗ · Free PDF ↗
Stress CT myocardial perfusion imaging after arterial switch operation for transposition of the great arteries.
This European Heart Journal—Imaging Methods and Practice study assessed feasibility and diagnostic performance of stress CT myocardial perfusion imaging (CT-MPI) in adults after arterial switch operation for transposition of the great arteries (ASO-TGA). Using regadenoson stress with either dynamic energy-integrating detector CT (EID-CT) with quantitative myocardial blood-flow mapping or static photon-counting detector CT (PCCT) with iodine-map assessment, the key finding was that stress CT-MPI could be performed and evaluated for coronary abnormalities that may be silent for decades after ASO. The work is significant because it supports CT-based functional assessment of late coronary complications in a population where invasive testing may be delayed.
Gkizas C, Longere B, Domanski O et al. · European heart journal. Imaging methods and practice · (2026) · View on PubMed ↗
Distinct relationships of compartment-specific fat distribution profiles with cardiovascular ageing and future cardiovascular events.
This Heart (British Cardiac Society) study examined how compartment-specific fat distribution profiles relate to biological cardiac ageing and future cardiovascular events in UK Biobank participants without existing cardiovascular disease. Using abdominal MRI measures of visceral adipose tissue (VAT), abdominal subcutaneous adipose tissue (ASAT), and pericardial adipose tissue (PAT) alongside machine-learning–derived biological heart age from 56 cardiac MRI phenotypes, the key finding was that distinct fat-depot patterns were associated with cardiac ageing metrics and incident CVD beyond standard anthropometric measures. The results are significant because they support imaging-defined obesity phenotyping as a more informative predictor of cardiovascular risk than BMI alone.
Maldonado-Garcia C, Salih AM, Neubauer S et al. · Heart (British Cardiac Society) · (2026) · View on PubMed ↗ · Free PDF ↗
Health Status Relationship to Ischemia and Coronary Artery Disease Severity in the ISCHEMIA Trial.
In a secondary analysis of the ISCHEMIA trial, investigators related baseline ischemia severity from stress testing (core laboratory assessment) and coronary anatomic severity from coronary computed tomography angiography (CCTA) to 1-year health status outcomes in participants with chronic coronary disease and moderate-to-severe ischemia. Greater ischemia and/or more severe coronary anatomy showed measurable associations with worse 1-year health status after randomization, quantified using proportional odds models adjusted for relevant covariates. This links objective ischemia/CAD burden to patient-centered outcomes, supporting more patient-relevant risk stratification when choosing invasive versus conservative strategies.
Phillips LM, Jones PG, Shaw LJ et al. · American heart journal · (2026) · View on PubMed ↗
Left ventricular myocardial strain impairment correlates with cerebral small vessel disease burden in patients with normal ejection fraction.
This cross-sectional study evaluated 139 participants with preserved left ventricular ejection fraction to test whether left ventricular myocardial strain impairment correlates with cerebral small vessel disease (CSVD) burden. Using concurrent cardiac and brain MRI, it assessed subclinical LV dysfunction via myocardial strain and compared it with neuroimaging CSVD markers to quantify the relationship. The results support a link between subtle cardiac dysfunction and cerebral microvascular injury, suggesting strain-based cardiac MRI could help identify individuals at higher CSVD risk.
Wang W, Zhang X, Liang M et al. · Brain research bulletin · (2026) · View on PubMed ↗ · Free PDF ↗
Coronary CT angiography-derived perivascular fat attenuation index as a potential marker for heart failure in hypertrophic cardiomyopathy.
This retrospective study evaluated coronary CT angiography (CCTA) perivascular fat attenuation index (FAI) as a marker of coronary inflammation in 75 patients with hypertrophic cardiomyopathy (HCM) and 75 matched controls. It found that perivascular FAI measured around the proximal right coronary artery (RCA), left anterior descending (LAD), and left circumflex (LCX) was associated with heart failure in HCM. The clinical significance is that CCTA-derived FAI could serve as a noninvasive imaging biomarker to identify HCM patients at higher HF risk.
Peng L, Feng Y, Yuan J et al. · The British journal of radiology · (2026) · View on PubMed ↗
Multimodality Imaging in Specific Cardiomyopathies/Diseases (e.g., Amyloidosis, HCM, ACM, MVP)
AL Cardiac Amyloidosis Mimicking Dilated Cardiomyopathy With Reduced Ejection Fraction and Absent Apical Sparing.
This JACC Case Reports article describes a patient with suspected dilated cardiomyopathy who was ultimately evaluated for cardiac amyloid light-chain (AL) disease using echocardiography and cardiac magnetic resonance (CMR). CMR demonstrated diffuse, patchy late gadolinium enhancement (with echocardiographic findings including reduced global longitudinal strain and absent apical sparing), supporting AL cardiac amyloidosis mimicking dilated cardiomyopathy. The case highlights the clinical importance of using advanced cardiac imaging to avoid delayed diagnosis and improve outcomes in rapidly progressive AL amyloidosis.
Kidess GG, Kaufman M, Sarswat N et al. · JACC. Case reports · (2026) · View on PubMed ↗ · Free PDF ↗
Left Ventricular Remodeling in Mitral Valve Prolapse: More Than Volume Overload.
This prospective multicenter study investigated left ventricular (LV) remodeling in nonsyndromic mitral valve prolapse (MVP) patients beyond mitral regurgitation (MR) volume overload, enrolling patients for cardiac magnetic resonance, 24-hour Holter monitoring, and assessment for cardiomyopathy-associated genetic variants. It tested whether an MVP cardiomyopathy substrate—potentially driven by ventricular arrhythmias and/or genetic predisposition—explains disproportionate LV remodeling. Scientifically, it advances the concept that MVP-related remodeling may reflect intrinsic myocardial disease rather than MR burden alone, informing risk assessment and mechanistic targeting.
Pype LL, Marchenko O, Van Laer SL et al. · Circulation. Cardiovascular imaging · (2026) · View on PubMed ↗
Imaging Cardiac Amyloidosis: From Early Diagnosis to Risk Stratification and Evaluation of Treatment Efficacy.
This review studied the role of multimodality cardiac imaging in patients with cardiac amyloidosis (AL or ATTR) across the diagnostic pathway, risk stratification, and treatment-response assessment. It found that echocardiography is the first-line imaging modality and that imaging stage of cardiac involvement is tightly linked to treatment efficacy and clinical outcomes. The work is clinically significant because it provides an imaging framework to enable earlier diagnosis and more accurate monitoring of disease-modifying therapy in AL/ATTR cardiac amyloidosis.
Sclafani M, Russo D, Oikonomou G et al. · Journal of cardiovascular development and disease · (2026) · View on PubMed ↗ · Free PDF ↗
Inflammatory Hot Phases in Arrhythmogenic Cardiomyopathy: A Dynamic Electrophysiologic Substrate Beyond Scar.
This JACC Advances review studied arrhythmogenic cardiomyopathy (ACM) with a focus on episodic inflammatory “hot phases” as a dynamic electrophysiologic substrate beyond established scar. It found that inflammatory exacerbations—potentially driven by mechanisms such as desmosomal instability, inflammasome activation, cytokine signaling, and anti-desmoglein-2 responses—can accelerate injury, scar formation, and arrhythmic vulnerability, with cardiac magnetic resonance tissue characterization proposed to detect these processes. The scientific significance is that it reframes ACM pathophysiology from static scar-only models toward inflammation-responsive risk and substrate assessment.
Zarghami M, Maleki ND, Naddaf S et al. · JACC. Advances · (2026) · View on PubMed ↗ · Free PDF ↗
Arrhythmogenic Mitral Valve Prolapse: Looking Beyond Mitral Regurgitation.
This JACC Case Reports series studied three men who developed left ventricular myocardial calcification after severe sepsis/septic shock or prolonged ICU admission. It found that computed tomography (CT) demonstrated the distribution and extent of calcium deposition while cardiac magnetic resonance (CMR) showed corresponding nonischemic late gadolinium enhancement. The significance is that multimodality imaging clarifies long-term postseptic myocardial injury patterns and supports more accurate diagnosis of this rare complication.
Ribeyrolles S, Zannis K, Berrebi A et al. · JACC. Case reports · (2026) · View on PubMed ↗ · Free PDF ↗
Myocardial Calcification After Severe Sepsis: 3-Patient Case Series, Multimodality Imaging, and Review of the Literature.
This JACC Case Reports article studied a 70-year-old woman with Barlow disease (mitral valve prolapse) who had an arrhythmogenic phenotype despite being evaluated primarily for mitral regurgitation (MR). It found that ambulatory ECG monitoring revealed frequent polymorphic premature ventricular complexes and that she subsequently suffered out-of-hospital ventricular fibrillation with cardiac arrest, with cardiac magnetic resonance used in the work-up. The clinical significance is that it highlights the need to look beyond MR severity to identify arrhythmogenic MVP risk using rhythm monitoring and advanced imaging.
Ruiz-López A, Salido Iniesta M, Gómez Revelles S et al. · JACC. Case reports · (2026) · View on PubMed ↗ · Free PDF ↗
Imaging-Guided Procedures & Interventional Cardiology (including CT-MPI, TPVI, iCMR)
The DiagnOsis of MINOCA (DOMINO) registry: a real-world use of multimodality imaging and its impact on etiologic classification.
The DOMINO registry study examined real-world adherence to European Society of Cardiology guideline recommendations for advanced diagnostic testing in 365 patients with MINOCA across 17 centers in 13 countries. It found that multimodality testing—defined as cardiac magnetic resonance (CMR), intracoronary imaging, and/or invasive coronary function testing—was used to improve etiologic classification, reflecting variable real-world implementation. The registry’s results are important for identifying gaps in MINOCA workup and improving diagnostic pathways to tailor therapy to underlying mechanisms.
Morrone D, Alberti M, Cravo J et al. · European journal of preventive cardiology · (2026) · View on PubMed ↗
Safety and Efficacy of HarmonyTM Transcatheter Pulmonary Valve Implantation - Clinical and Hemodynamic Assessment in a Single-Center Japanese Cohort.
This prospective single-center Japanese cohort study evaluated the safety and hemodynamic performance of HarmonyTM transcatheter pulmonary valve implantation (TPVI) in 55 Japanese adults with pulmonary regurgitation (PR) and an enlarged native right ventricular outflow tract. Procedural success and early follow-up echocardiography/CMR at baseline and 3 months were used to assess outcomes, demonstrating feasibility and favorable early hemodynamic results in this non-US population. The findings are clinically important because they extend evidence for HarmonyTM TPVI to a Japanese cohort, supporting broader generalizability of TPVI outcomes across regions.
Kogure T, Yagishita D, Kawamoto T et al. · Circulation journal : official journal of the Japanese Circulation Society · (2026) · View on PubMed ↗ · Free PDF ↗
Volumetric real-time MRI for the guidance of cardiac catheterization at 0.55T.
This engineering/feasibility study proposed volumetric real-time interventional cardiovascular MRI (iCMR) at 0.55T to guide cardiac catheterization, specifically right-heart catheterization (RHC). It introduced a volumetric method that images the heart and great vessels in their entirety, enabling flexible real-time re-slicing and 3D visualization to better track devices as they move out of plane. The significance is that volumetric iCMR could reduce operational burden and improve procedural guidance accuracy compared with interleaved multi-planar 2D approaches.
Kumar P, Ramasawmy R, Javed A et al. · Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · (2026) · View on PubMed ↗ · Free PDF ↗
Congenital Heart Disease Long-Term Outcomes & Functional Assessment
Natural history of children after tetralogy of Fallot repair.
This single-center retrospective cohort study characterized the contemporary natural history of children and adolescents after tetralogy of Fallot repair (rTOF) in 95 patients followed for a median of 15.7 years. Over long-term follow-up, serial assessments using ECG, echocardiography, Holter monitoring, cardiovascular magnetic resonance (CMR), and cardiopulmonary exercise testing (CPET) documented evolving clinical status and late outcomes through age 18. These data help clinicians counsel families and refine long-term surveillance strategies for rTOF patients treated in the modern surgical and follow-up era.
Bitterman Y, Bulic A, Mueller B et al. · Pediatric research · (2026) · View on PubMed ↗
Model-informed optimal dose selection of golcadomide in combination with R-CHOP in patients with previously untreated aggressive B-cell lymphoma.
This prospective study evaluated cardiorespiratory fitness and its determinants in children with surgically corrected congenital heart disease (CHD) by combining cardiopulmonary exercise testing (CPET) with biventricular cardiac imaging. Children with corrected biventricular CHD showed reduced exercise capacity (lower maximal oxygen uptake, V̇O2max) and the study aimed to relate CPET impairment patterns to biventricular functional measures. The results are intended to clarify which cardiovascular versus ventilatory/gas-exchange limitations drive exercise intolerance, informing targeted rehabilitation and follow-up.
Zheng X, Yu Z, Kaplan M et al. · British journal of clinical pharmacology · (2026) · View on PubMed ↗ · Free PDF ↗
Cardiovascular Imaging in Pediatrics & Special Populations
Late cardiac effects of anthracycline-based therapy in childhood cancer survivors: a CMR study of cardiac strain and function.
This cross-sectional observational study assessed childhood cancer survivors (CCS) approximately 12 years after anthracycline-based therapy, comparing 117 CCS with 79 age- and sex-matched controls using cardiovascular magnetic resonance feature tracking (CMR-FT) strain metrics. It aimed to determine whether CMR-FT–derived ventricular strain (including global longitudinal, circumferential, and radial strain for both ventricles) detects subclinical cancer therapy–related cardiac dysfunction (CTRCD). If validated, CMR-FT strain could improve long-term surveillance for late anthracycline cardiotoxicity in CCS.
Mojica-Pisciotti ML, Panovský R, Holeček T et al. · Clinical research in cardiology : official journal of the German Cardiac Society · (2026) · View on PubMed ↗
Cardiovascular Imaging in Systemic/Inflammatory/Autoimmune Conditions
Myocardial Fibrosis in Pediatric Heart Disease: Mechanisms, Imaging Biomarkers, Clinical Consequences, and Emerging Antifibrotic Therapies.
This review summarized mechanisms and clinical consequences of myocardial fibrosis in pediatric heart disease, covering congenital and acquired conditions (including cardiomyopathies, myocarditis, pulmonary hypertension, and cancer therapy-related cardiotoxicity) and the imaging biomarkers used to detect fibrosis. It emphasized that pediatric myocardial fibrosis is dynamic—driven by inflammation, neurohormonal activation, oxidative stress, and fibroblast-to-myofibroblast transformation—rather than purely irreversible scarring. The review is significant because it frames emerging antifibrotic therapies and imaging strategies to mitigate long-term remodeling and outcomes in children.
Asghar U, Choudhry S, Jabeen M et al. · Cardiology in review · (2026) · View on PubMed ↗
From ANCA-mediated vascular injury to coronary microvascular and myocardial involvement in granulomatosis with polyangiitis: an immunocardiology perspective.
This immunocardiology-focused review examined how ANCA-mediated vascular injury in granulomatosis with polyangiitis (GPA) contributes to coronary microvascular dysfunction and myocardial involvement. It synthesizes evidence that cardiovascular risk in GPA arises from interacting mechanisms including conventional risk factors, treatment-related metabolic effects, renal dysfunction, systemic inflammation, and GPA-specific vascular injury. The review highlights mechanistic targets and imaging/biomarker pathways that could guide future cardiovascular risk assessment and therapy in GPA.
Lucki M, Grygiel-Górniak B, Lucka E et al. · Rheumatology international · (2026) · View on PubMed ↗ · Free PDF ↗
Loeffler’s Endomyocarditis With Embolic Stroke Secondary to Chronic Eosinophilic Leukemia With Therapy-Related Molecular Features.
This JACC Case Reports article studied a 77-year-old man with chronic eosinophilic leukemia (arising after diffuse large B-cell lymphoma treated with R-CHOP) who developed Loeffler’s endomyocarditis with an apical left ventricular thrombus and embolic stroke. Imaging with echocardiography and CMR showed diffuse subendocardial involvement and thrombus consistent with eosinophil-mediated myocardial injury, in the context of therapy-related molecular features suggesting a clonal eosinophilic disorder. The report emphasizes that clonal hypereosinophilia can drive high-risk cardiac thromboinflammatory disease and that early recognition is critical to prevent further embolic events.
Ramesh S, Yousif N, Affas Z et al. · JACC. Case reports · (2026) · View on PubMed ↗ · Free PDF ↗
Cardiac myxoedema due to severe hypothyroidism mimicking myopericarditis: a case report.
This European Heart Journal Case Reports article studied a 42-year-old woman with severe hypothyroidism presenting with recurrent chest pain initially suspected to be myopericarditis after SARS-CoV-2 infection. The key finding was that cardiac myxoedema (myocardial and pericardial involvement from hypothyroidism) mimicked myopericarditis, with echocardiography showing preserved biventricular systolic function and a circumferential pericardial effusion pattern consistent with the reversible endocrine cause. The case is clinically significant because recognizing cardiac myxoedema can prevent misdiagnosis and enable timely thyroid-directed treatment.
Gualini E, Pedrotti P, Dalino Ciaramella P et al. · European heart journal. Case reports · (2026) · View on PubMed ↗ · Free PDF ↗
Pericardial Hemangioma: An 8-Year Diagnostic Odyssey of Recurrent Pleural Effusion.
This case report described a 54-year-old woman with an 8-year history of recurrent pleural/pericardial effusions initially misattributed to amyloidosis, ultimately diagnosed with pericardial hemangioma. Cardiac magnetic resonance (CMR) demonstrated a transverse pericardial sinus mass with characteristic T2 hyperintensity and centripetal enhancement, and histology confirmed hemangioma after surgical excision with no recurrence at 4-year follow-up. The report is clinically important because it illustrates how CMR can distinguish pericardial hemangioma from inflammatory or malignant mimics and prevent prolonged diagnostic delay.
Castillo M, Ibáñez A, Cuevas O et al. · JACC. Case reports · (2026) · View on PubMed ↗ · Free PDF ↗
Management of pericarditis: recent advances.
This narrative review summarized recent advances in pericarditis management, emphasizing a shift from empiric anti-inflammatory treatment to mechanism-based, risk-stratified, and imaging-supported care. It highlighted that diagnosis remains primarily clinical (typical chest pain, rub, ECG changes, effusion) but that inflammatory biomarkers and multimodality imaging—especially cardiac magnetic resonance—improve diagnostic confidence and guide therapy. The review is significant for clinicians because it consolidates contemporary strategies to tailor treatment intensity and differential diagnosis in acute pericarditis.
Imazio M · Polish archives of internal medicine · (2026) · View on PubMed ↗ · Free PDF ↗
Cardiovascular Sequelae After SARS-CoV-2 in Children: From Myocardial Injury to Dysautonomia and Implications for Phenotype-Guided Follow-Up.
This narrative review synthesized pediatric evidence (2020 to 30 May 2026) on long-term cardiovascular sequelae after SARS-CoV-2 infection, emphasizing multisystem inflammatory syndrome in children (MIS-C), persistent subclinical myocardial abnormalities, and autonomic dysfunction. It concluded that the literature spans the full spectrum of acute disease severity and supports a need for structured follow-up focused on myocardial and autonomic outcomes. The review’s clinical implication is phenotype-guided monitoring strategies for children after SARS-CoV-2 and MIS-C to detect late cardiovascular complications.
Mól N, Kwinta P · Pediatric cardiology · (2026) · View on PubMed ↗ · Free PDF ↗
MxA expression in systemic lupus erythematosus -associated myocarditis indicates type I interferon pathway activation.
This case-based study investigated myocarditis associated with systemic lupus erythematosus (SLE) in two patients to determine whether local type I interferon pathway activation is reflected by cardiac myxovirus resistance protein A (MxA) expression. In both cases, MxA expression in myocarditis indicated type I interferon pathway activation, supporting MxA as a local surrogate marker of IFN activity in SLE myocarditis. These observations strengthen the mechanistic link between type I interferon signaling and cardiac inflammation in SLE, potentially informing targeted therapeutic strategies.
Ito Y, Arinuma Y, Yuasa H et al. · Immunological medicine · (2026) · View on PubMed ↗ · Free PDF ↗
Giant cell myocarditis: from immune pathogenesis to contemporary management.
This narrative review studied giant cell myocarditis (GCM) with emphasis on immune pathogenesis and contemporary management strategies. It found that GCM is predominantly a T cell–mediated autoimmune disorder with contributions from macrophage-derived multinucleated giant cells and neutrophil extracellular trap formation, and that without immunosuppression median transplant-free survival is about three months. The clinical significance is that it supports early recognition and prompt immunosuppressive treatment to reduce rapid deterioration, malignant arrhythmias, and the need for heart transplantation.
Vosko I, Wallner M · Heart failure reviews · (2026) · View on PubMed ↗ · Free PDF ↗
Immunocardiology & Transplant/Immunotherapy Monitoring
9-Year Serial CMR Monitoring of Cardiac AL Amyloidosis Regression After Teclistamab.
This JACC Case Reports report described 9-year serial CMR monitoring of cardiac AL amyloidosis regression after B-cell maturation antigen (BCMA)–directed therapy with teclistamab in a 64-year-old man. Over 11 CMR examinations, the patient showed a biphasic course with progressive infiltration through 2020 followed by sustained structural and functional improvement after teclistamab, despite prior failure of four lines including daratumumab. The case is clinically significant because it provides rare long-term CMR evidence that teclistamab can produce durable cardiac regression in symptomatic cardiac AL amyloidosis.
Silvestri V, Toledano M, Hivert B et al. · JACC. Case reports · (2026) · View on PubMed ↗
Extracorporeal Photopheresis in Heart Transplantation: Mechanisms, Clinical Integration, and the Experience of the Azienda Ospedaliera Universitaria Senese.
This Artificial Organs review studied extracorporeal photopheresis (ECP) in heart transplant recipients, focusing on mechanisms and real-world clinical integration at Azienda Ospedaliera Universitaria Senese. The key finding was that ECP—combining leukapheresis, 8-methoxypsoralen photoactivation, and UVA irradiation—induces leukocyte apoptosis and promotes immune tolerance via dendritic-cell modulation, regulatory T-cell expansion, and cytokine reprogramming, with clinical evidence supporting use in steroid-refractory acute cellular rejection and selected antibody-mediated rejection. The review is significant because it consolidates mechanistic rationale and practical experience to guide immunosuppressive strategy in complex transplant rejection.
Martini L, Righini FM, Selimi A et al. · Artificial organs · (2026) · View on PubMed ↗ · Free PDF ↗
Machine Learning/AI for Imaging Automation & Prognosis
Dual-flow convolutional neural network for automatic measurement of left ventricular ejection fraction and global longitudinal strain in echocardiography.
This work developed and validated a dual-flow convolutional neural network (Echo-DFCNN) to automatically measure left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS) from echocardiography videos in 500 patients (1,500 videos) from an internal center and 363 patients (1,089 videos) from four external centers. The model enabled synchronous, rapid, and accurate estimation of LVEF and GLS, addressing inter-observer variability and labor-intensive workflows. This is scientifically and clinically significant because automated strain/LVEF quantification could standardize echocardiographic assessment and improve prognostic decision-making.
Zhang Z, Zhu Y, Chen S et al. · PLOS digital health · (2026) · View on PubMed ↗
Artificial intelligence-derived myocardial fibrosis on cardiac magnetic resonance for prognosis in cardiomyopathy: A systematic review of a sparse evidence base.
This systematic review assessed whether artificial intelligence (AI)-derived myocardial fibrosis quantification from cardiac magnetic resonance (CMR)—including late gadolinium enhancement (LGE) and parametric mapping—adds independent prognostic value in adults with ischemic or nonischemic cardiomyopathy. Across eligible studies with covariate-adjusted outcomes over at least 12 months, the evidence base was sparse and heterogeneous, limiting firm conclusions about incremental prognostic performance beyond standard fibrosis measures. Clinically, it highlights the need for larger, well-controlled AI-CMR fibrosis studies to validate robust risk prediction for cardiomyopathy outcomes.
Siddiqi AK, Khan AR, Khan S et al. · Current problems in cardiology · (2026) · View on PubMed ↗
Metabolic Signatures of Atrial Functional Impairment in Paroxysmal Atrial Fibrillation Patients: A CMR Strain-metabolomics Study.
This CMR strain–metabolomics study evaluated paroxysmal atrial fibrillation (PAF) patients by combining cardiac magnetic resonance atrial strain analysis with untargeted metabolomics to identify biomarkers of early, potentially reversible atrial dysfunction. Despite similar left atrial sizes, PAF patients showed significant differences in atrial strain and seven differential metabolites (phosphatidylcholine, inosine, bilirubin, biliverdin, 3-methylhistidine, L-tryptophan, and pantothenic acid) associated with declining atrial function. These metabolic signatures could support earlier phenotype-guided biomarker development to delay progression of atrial fibrillation.
Shi T, Liu B, Lian X et al. · Journal of cardiovascular translational research · (2026) · View on PubMed ↗
AI/Imaging Standardization & Reference Ranges
Technical challenges in establishing local native T1 reference ranges in cardiac MRI: a critical review.
This critical review examined the technical challenges of establishing local native T1 reference ranges in cardiac MRI, focusing on how scanner and acquisition variables affect myocardial T1 measurements. It found that native T1 values vary substantially with magnetic field strength and B0/B1 homogeneity, as well as across vendors, protocols, and specific acquisition parameters, limiting cross-center comparability. The review highlights the need for standardized, locally validated T1 mapping workflows to improve reliable detection of myocardial fibrosis and other tissue abnormalities.
Che Ha M, Sayuti KA, Mohammed Y et al. · Insights into imaging · (2026) · View on PubMed ↗ · Free PDF ↗
Normative values for quantitative MRI biomarkers of the liver in collegiate athletes.
This study established normative quantitative liver MRI biomarker values in collegiate athletes, focusing on proton density fat fraction (PDFF), R2*-based liver iron concentration (LIC), and T1/T2 relaxation times. Using chemical shift–encoded MRI for whole-liver PDFF and R2* and cardiac mapping with partial liver coverage for T1/T2, it generated athlete-specific reference ranges using return-to-play liver MRI after COVID-19 recovery at 1.5T/3.0T. These norms can improve interpretation of liver fat and iron metrics in athletes and reduce misclassification when assessing liver health.
Anagnostopoulos A, Heidenreich JF, Roshanshad A et al. · Magnetic resonance imaging · (2026) · View on PubMed ↗
Non-Cardiac/Non-Imaging Biomedical Research (Infection, Oncology, Redox Chemistry, etc.)
Trends and disparities in colorectal cancer mortality among adults with diabetes mellitus in the United States: A retrospective analysis, 1999-2025 and projections to 2040.
This retrospective U.S. national mortality analysis studied colorectal cancer (ICD-10 C18–C20) deaths among adults with diabetes mellitus (E10–E14) aged ≥45 years from 1999–2025, with age-adjusted mortality trends assessed via joinpoint regression and projections to 2040. The study found disparities and time trends in CRC mortality among people with diabetes, indicating changing risk patterns over the period (details truncated in the provided abstract). These findings are clinically significant for targeting CRC prevention and screening strategies in U.S. adults with diabetes and for anticipating future CRC mortality burden through 2040.
Tablawy M, Ibrahim AA, Badawi AA et al. · Journal of diabetes and metabolic disorders · (2026) · View on PubMed ↗
Emerging experimental and computational methods for studying redox-regulated structural transitions.
This FEBS Letters review studied emerging experimental and computational approaches to characterize thiol-based redox-regulated structural transitions, focusing on cysteine and selenocysteine modifications and the challenge of capturing transient oxidative intermediates. It reports that chemoselective small-molecule probes can trap/enrich specific sulfenic and sulfinic acid states and that machine-learning–driven graph-based methods are increasingly used to reduce the computational burden of classical molecular dynamics. The work is significant for enabling atomic-level thermodynamic/kinetic understanding of redox switching mechanisms that underpin metabolic regulation and signaling.
Rass T, Reichmann D, Erdős G · FEBS letters · (2026) · View on PubMed ↗
Long-term results of brentuximab vedotin and bendamustine for first-line treatment of Hodgkin lymphoma in the elderly (HALO trial).
This British Journal of Haematology report studied long-term outcomes of first-line brentuximab vedotin (Adcetris) plus bendamustine (Levact/Be) in elderly patients with Hodgkin lymphoma enrolled in the HALO phase I/II trial. The key finding was the durability of safety and efficacy signals from this Be–BV frontline regimen in an older population (mean age ~70.8 years) with advanced-stage disease distribution and frequent high International Prognostic Score (IPS) features. The results are significant because they address the limited therapeutic window in eHL and provide evidence to guide frontline treatment selection for older adults.
Gallamini A, Viviani S, Rapezzi D et al. · British journal of haematology · (2026) · View on PubMed ↗ · Free PDF ↗
Risk factors for hypothermia on trauma center arrival in injured children.
This retrospective cohort study used the 2021–2023 Trauma Quality Improvement Program dataset to identify predictors of hypothermia at pediatric trauma center arrival and factors associated with missing temperature documentation in children under 18 years. It found that specific clinical and documentation-related risk factors were associated with arrival hypothermia and with incomplete temperature recording. The results are significant for improving early recognition and quality of temperature monitoring in injured children, which may reduce downstream morbidity from hypothermia.
Rempson CM, Crosier CJ, Pracht EE et al. · The journal of trauma and acute care surgery · (2026) · View on PubMed ↗
A plasmid-associated immunoglobulin-binding protein in Acinetobacter baumannii.
This study investigated virulence determinants in 89 carbapenem-resistant Acinetobacter baumannii clinical isolates, using animal infection models and comparative genomics to identify plasmid-encoded factors, focusing on the type D plasmid immunoglobulin-binding protein ImbA. ImbA was characterized as an immunoglobulin-binding protein with measurable protein–immunoglobulin interactions assessed by pull-down assays and biolayer interferometry. These findings identify a specific plasmid-associated virulence factor that could be targeted to reduce severe A. baumannii infection outcomes in multidrug-resistant settings.
Kim D, Kim C, Lee S et al. · EBioMedicine · (2026) · View on PubMed ↗ · Free PDF ↗
Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial.
This phase 3, randomized, double-blind, placebo-controlled trial (HOPE-3) studied deramiocel, a heart-derived cellular therapy of human allogeneic cardiosphere-derived cells, in participants aged ≥10 years with advanced Duchenne muscular dystrophy (DMD). The trial was designed to evaluate deramiocel’s efficacy and safety in advanced DMD to confirm findings from HOPE-2, using intravenous infusion and comparing outcomes versus placebo. If effective, deramiocel could become a disease-modifying adjunct therapy for DMD-related cardiomyopathy and functional decline.
McDonald CM, Villa C, Soslow JH et al. · Lancet (London, England) · (2026) · 2 citations · View on PubMed ↗ · Free PDF ↗
The Effect of Different Types of Adhesive Systems on Marginal Integrity of Class II Resin Composite Restoration.
This in vitro dental study evaluated how different adhesive systems affect marginal integrity of Class II resin composite restorations using cervical margin relocation (CMR) or deep margin elevation (DME). It found that restorations made with a universal adhesive (Single Bond Universal) in either etch-and-rinse or self-etch modes, compared with OptiBond FL (OptiBond FL) and Clearfil SE Bond (Clearfil SE Bond), differed in marginal integrity after 6 months of water aging. The scientific significance is that it provides evidence for selecting adhesive systems and application modes to improve restoration margins in CMR/DME techniques.
Phuntusuntorn P, Engkatanachai K, Singhatanadgit W et al. · The journal of adhesive dentistry · (2026) · View on PubMed ↗ · Free PDF ↗
Understanding the cardiology training landscape in Asia-Pacific region.
This cross-sectional survey studied cardiology training and credentialing pathways across the Asia-Pacific by collecting responses from credentialed cardiologists representing 23 regions using a 42-item online questionnaire (data as of December 2023). The key finding was that all regions required specialist qualification to practise cardiology, with 69.6% reporting a single training pathway and additional proportions reporting multiple pathways (21.7% and 8.7% as described in the abstract). Scientifically and for curriculum planning, mapping these regional differences and similarities can inform harmonized cardiology training and credentialing strategies tailored to Asia-Pacific needs.
Cader FA, Lee WYS, Widodo WA et al. · Postgraduate medical journal · (2026) · View on PubMed ↗
Generated automatically on August 28, 2026. Covers PubMed articles published August 21, 2026 – August 28, 2026. Summaries are AI-generated; always consult the original publication for clinical or research decisions.